|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Tumor size predicts survival within stage IA non-small cell lung cancer 显示文摘 | Port JL Kent MS Korst R J | 2003 | Chest2003，124，5： | 1 |
| 2 | Surgery for thymoma显示文摘 | Port JL Ginsberg RJ | | 0，，02： | 1 |
| 3 | Tumor size is a determinant of stage distribution in tl non-small cell lung cancer显示文摘 | Flieder DB Port JL Korst RJ | 2005 | Chest2005，128，： | 1 |
| 4 | Risk factors for occult me- diastinal metastases in clinical stage I non-small cell lung cancer显示文摘 | Lee PC Port JL Korst RJ | 2007 | Ann ThoraeSurg2007，84，1： | 1 |
| 5 | Tumor size is a determinant of stage distribution in T1 non-small cell lung cancer显示文摘 | Flieder DB Port JL Korst RJ | 2005 | Chest2005，128，4： | 1 |
| 6 | Localization of insulin receptor mRNA in rat brain by in situ hybridization 显示文摘 | Marks JL Porte D Jr Stahl WL | 1990 | Endo- crinology1990，127，： | 1 |
| 7 | Cigarette smoking and risk of lung metastasis from esophageal cancer 显示文摘 | Abrams JA Lee PC Port JL | 2008 | Cancer Epidemiol Biomarkers Prev2008，17，10： | 1 |
| 8 | Positron emission tomography scanning poorly predicts response to preoperative chemotherapy in non-small cell lung cancer显示文摘 | Port JL Kent MS Korst RJ | 2004 | Ann Thorac Surg2004，77，1： | 1 |
| 9 | Celecoxib,a selective cyclo-oxygenase-2 inhibitor,enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer显示文摘 | Altorki NK Keresztes RS Port JL | 2003 | J Clin Oncol2003，21，14： | 1 |
| 10 | Celecoxib, a selective cyclooxygenase 2 inhibitor, enhances the response to preopera- tive paclitaxel and carboplatin in early-stage non small cell lung cancer显示文摘 | Altorki NK Keresztes RS Port JL | 2003 | J Clin Oncol2003，21，14： | 1 |
| 11 | Risk factors for occult mediasti- nal metastases in clinical stage I non-small cell lung cancer 显示文摘 | Lee PC Port JL Korst R J | 2007 | Ann Thorac Surg2007，84，1： | 1 |
| 12 | Celecoxib, a selective cyclooxygenase-2inhibitor, enhances the response to pre-operative paclitaxel and carboplatin in early stage non-small cell lung cancer显示文摘 | Ahorki NK Keresztes RS Port JL | 2003 | J Clin Oncol2003，21，14： | 1 |
| 13 | Thymoma : a multivariate analysis of factors predicting survival显示文摘 | Blumberg D Port JL Weksler B | 1995 | Ann Thorac Surg1995，60，4： | 1 |
| 14 | Thoracic esophageal perforations:a decade of experience显示文摘 | Port JL Kent MS Korst R J | | 0，，04： | 1 |
| 15 | Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors显示文摘 | Port FK Bragg-Gresham JL Metzger RA | 2002 | Transplantation2002，74，9： | 1 |
| 16 | Celecoxib,a se- lective eyelonxygenase-2 inhibitor,enhances the response to preoperative paclitaxel andcarboplatin in early-stage non-small-cell lung cancer 显示文摘 | Ahorki NK Keresztes RS Port JL | 2003 | J Clin Oncol2003，21，14： | 1 |
| 17 | Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer 显示文摘 | Altorki NK Keresztes RS Port JL | 2003 | J Clin Oncol2003，21，14： | 1 |
| 18 | Risk factors for occult mediasti- nal metastases in clinical stage I non-small cell lung cancer显示文摘 | Lee PC Port JL Korst RJ | 2007 | Ann Thorac Surg2007，84，： | 1 |
| 19 | Thymoma;a multivariate analysis of factors predicting survival 显示文摘 | Blumberg D Port JL Weksler B | 1995 | Ann Thoracic Surg1995，50，： | 1 |
| 20 | Celecoxib,a selective cyclooxygenase-2 inhibitor,enhances the response to preoperative paclitaxel and carboplatin in early-stage non-smallcell lung cancer显示文摘 | Altorki NK Kereszies RS Port JL | 2003 | J Clin Oncol2003，21，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员